Recurrent hypo-attenuated leaflet thickening after TAVR: Clinical implications
Department
Internal Medicine
Additional Department
Cardiology
Document Type
Article
Publication Title
Catheterization and Cardiovascular Interventions
Abstract
Subclinical bioprosthetic valve thrombosis (BPVT) is a relatively common finding in asymptomatic patients during follow-up imaging. However, its clinical significance is unclear. Data from registries associate BPVT with elevated valve gradients, thromboembolic complications, recurrence, and valve degeneration. Given the dynamic nature of the disease process, management is challenging. The duration of anticoagulation is unpredictable, and the need for frequent monitoring of BPVT, even in subclinical scenarios, is unclear. Our report is shedding the light on the clinical implications BPVT.
First Page
1156
Last Page
1158
DOI
10.1002/ccd.31017
Volume
103
Issue
7
Publication Date
6-1-2024
Medical Subject Headings
Humans; Heart Valve Prosthesis; Transcatheter Aortic Valve Replacement (adverse effects, instrumentation); Aortic Valve (surgery, diagnostic imaging, physiopathology); Aortic Valve Stenosis (surgery, diagnostic imaging, physiopathology); Bioprosthesis; Treatment Outcome; Recurrence; Thrombosis (etiology, diagnostic imaging); Aged, 80 and over; Male; Prosthesis Design; Female; Anticoagulants (therapeutic use); Aged; Time Factors
PubMed ID
38529691
Recommended Citation
Takla, A., Sourial, K., & Sharma, G. (2024). Recurrent hypo-attenuated leaflet thickening after TAVR: Clinical implications. Catheterization and Cardiovascular Interventions, 103 (7), 1156-1158. https://doi.org/10.1002/ccd.31017